
NanoBioFAB
A startup aiming to bring Nanotechnology to the wearable tech space.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | $250k Valuation: $1.8m | Seed | |
Total Funding | 000k |
Related Content
NanoBioFAB, founded in 2016 by Dr. Xiaonao Liu and Dr. Ruoting Yang, is a Frederick, Maryland-based medical device manufacturer operating at the intersection of nanotechnology and artificial intelligence. The company's genesis is tied to a personal story: the loss of Dr. Liu's father-in-law to leukemia, which motivated her and her husband, Dr. Yang, to combine their expertise to advance early disease detection. Dr. Liu has over 18 years of experience in nanomaterial science and chemical engineering, including a role as a nanomaterial fabrication specialist at Caltech. Dr. Yang is an expert in biomarker research and AI, with a Ph.D. in Systems Science and Mathematics.
The firm develops and manufactures AI-powered smart nanosensors designed for the healthcare market, with a focus on real-time pathogen detection and wound management. Its core technology utilizes a proprietary, high-throughput 3D nano-printing and screening platform to create sensors that can detect minute quantities of gases emitted from skin and breath, as well as measure pressure, temperature, and humidity. This platform significantly shortens the research and development timeline for new sensor products from years to months. NanoBioFAB's business model includes licensing its technology, selling data access to partners, and engaging in co-development projects. The company serves hospital systems, enterprise partners, and military healthcare, with applications in orthopedics, wound care, urology, and pulmonology. A key product, WoundSentry, integrates these nanosensors into smart bandages to continuously monitor for bacterial growth, providing early warnings of infection without disturbing the wound dressing.
NanoBioFAB has secured multiple rounds of funding and support, including investments from TEDCO's Builder Fund and grants from the Defense Health Agency (DHA). The company holds numerous patents for its technology and has a contract with the U.S. Department of Defense. The ultimate goal is to provide medical professionals with a more efficient way to monitor patients, enabling timely intervention that can improve outcomes and reduce healthcare costs.
Keywords: pathogen detection, nanosensors, artificial intelligence, medical devices, wound care, real-time monitoring, healthcare technology, 3D nano-printing, telemedicine, diagnostic tools, biomarker research, smart bandages, infection detection, defense healthcare, nanomaterials, gas sensors, personalized healthcare, clinical infection management, non-invasive diagnostics, medtech